Novavax
NVAX
124 hedge funds and large institutions have $334M invested in Novavax in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 46 increasing their positions, 18 reducing their positions, and 5 closing their positions.
720% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 5
156% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 18
135% more capital invested
Capital invested by funds: $142M → $334M (+$192M)
39% more funds holding
Funds holding: 89 → 124 (+35)
39% more call options, than puts
Call options by funds: $2.64M | Put options by funds: $1.9M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.9M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$10.2M |
| 4 |
HM
HealthCor Management
New York
|
+$9.85M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$8.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$7.95M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$224K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$187K |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$176K |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$145K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
126
Principal Financial Group
Des Moines,
Iowa
| – | -$145K | -3,544 | Closed |
|
127
Invesco
Atlanta,
Georgia
| – | -$96K | -2,335 | Closed |
|
|
CA
128
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| – | -$73K | -1,780 | Closed |
|
|
RCM
129
Rotella Capital Management
Bellevue,
Washington
| – | -$21K | -500 | Closed |
|
NVAX Hedge Fund Activity: Q3 2013 in Review
124 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2013, worth a combined $334M — up 135% from $142M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NVAX positions and 5 closed out — a net gain of 36 holders — while 46 added to existing stakes and 18 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $13.9M. The largest seller was BlackRock Advisors, cutting an estimated $7.95M.
- 124 institutional investors held Novavax (NVAX) as of Q3 2013, up from 89 in Q2 2013.
- Funds reported $334M of Novavax stock for Q3 2013, up 135% quarter-over-quarter.
- 41 funds opened new Novavax positions in Q3 2013 and 5 closed out, a net change of +36 holders.
- The largest Novavax buyer in Q3 2013 was Wellington Management Group, an estimated $13.9M added.
- The largest Novavax seller in Q3 2013 was BlackRock Advisors, an estimated $7.95M sold.
Based on aggregated 13F filings for Q3 2013.